Using machine learning to analyze medical imaging seems like an obvious application for the novel visualization tools that have been developed over the past decade, and now a clutch of investors have backed Subtle Medical — a company that aims to bring those technologies to the healthcare market.
The company has raised $12.2 million in a new round of funding from investors including: 3E Bioventures Capital with participation from Fusion Fund, Data Collective, Delta Ventures, Tsingyuan Ventures and its seed investors.
The company’s technology has been FDA-cleared and CE-marked and is used to boost image quality and speed up analysis of diagnostic scans, according to a statement.
“Our mission is to make medical imaging better, safer and more comfortable for patients while creating new workflow efficiencies for hospitals and imaging centers,” said Dr. Enhao Gong, the company’s founder and chief executive, in a statement.
Subtle Medical’s technology is already being used in 50 locations around the world including Affidea, which is the largest imaging service in the European Union.
The company said it would use the new financing to accelerate its go-to-market strategy and its product development.
“Subtle Medical is paving the way for a new generation of AI-powered medical imaging. In a short time, the company has proven to have a profound impact on the radiology community, and the value they bring to improve patient care and increase scanner capacity is instrumental and timely in the current healthcare environment,” said Dr. Lue Sun, Vice President at 3E Bioventures.